| Literature DB >> 26576844 |
Su-Jin Park1, Mukesh Kumar2, Hyeok-il Kwon1, Rak-Kyun Seong3, Kyudong Han4, Jae-min Song5, Chul-Joong Kim6, Young-Ki Choi1, Ok Sarah Shin3,7.
Abstract
Emerging outbreaks of newly found, highly pathogenic avian influenza (HPAI) A(H5N8) viruses have been reported globally. Previous studies have indicated that H5N8 pathogenicity in mice is relatively moderate compared with H5N1 pathogenicity. However, detailed mechanisms underlying avian influenza pathogenicity are still undetermined. We used a high-throughput RNA-seq method to analyse host and pathogen transcriptomes in the lungs of mice infected with A/MD/Korea/W452/2014 (H5N8) and A/EM/Korea/W149/2006 (H5N1) viruses. Sequenced numbers of viral transcripts and expression levels of host immune-related genes at 1 day post infection (dpi) were higher in H5N8-infected than H5N1-infected mice. Dual sequencing of viral transcripts revealed that in contrast to the observations at 1 dpi, higher number of H5N1 genes than H5N8 genes was sequenced at 3 and 7 dpi, which is consistent with higher viral titres and virulence observed in infected lungs in vivo. Ingenuity pathway analysis revealed a more significant upregulation of death receptor signalling, driven by H5N1 than with H5N8 infection at 3 and 7 dpi. Early induction of immune response-related genes may elicit protection in H5N8-infected mice, which correlates with moderate pathogenicity in vivo. Collectively, our data provide new insight into the underlying mechanisms of the differential pathogenicity of avian influenza viruses.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26576844 PMCID: PMC4649622 DOI: 10.1038/srep16512
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Global overview of the RNA-seq data of H5N8- and H5N1-infected mice lungs.
A global overview of RNA-seq data of mice infected with mock, H5N8 virus, or H5N1 virus is shown. Lungs from three mice per group were harvested at 1, 3, and 7 days post infection (dpi). RNA-seq was performed for 21 samples. (A) Numbers of more than 2 fold up or down-regulated differentially expressed genes (DEGs) identified from the comparison among mock and virus-infected groups (DEGs were identified based on a false discovery rate (FDR) q-value threshold of less than 0.05). (B) Venn diagrams of overlapping DEG profiles for H5N8 and H5N1. DEGs are those displaying a change of more than two-fold with a p-value of less than or equal to 0.05. The mRNA differential expressions in H5N8- and H5N1-infected mice are depicted in three overlapping circles for 2-fold up and down-regulation at 1, 3, and 7 dpi. The numbers indicate the mRNA counts in the indicated area. (C) Volcano plot showing DEGs for H5N1- and H5N8-infected mice. The x-axis represents the log2 values of the fold change observed for each mRNA transcript, and the y-axis represents the log10 values of the p-values of the significance tests between replicates for each transcript. Data for genes that were not classified as differentially expressed are plotted in black.
Figure 2Analysis of viral gene expression changes in the lungs of H5N8- and H5N1-infected mice.
Viral gene transcript reads of NA, NP, HA, M, PA, PB1, PB2, and NS are shown. The graph shows mean ± standard deviation of values from three mice per group. Statistical analysis: *p < 0.05 comparing H5N1 and H5N8.
Top 10 up-regulated differentially expressed genes (DEGs) in H5N8- and H5N1-infected mice.
| Dpi | H5N8 | Log2FC | p-value | H5N1 | Log2FC | p-value |
|---|---|---|---|---|---|---|
| 1 dpi | Keratin 1 | 6.56 | 0.00005 | RIKEN cDNA C920009B18 gene | 7.43 | 0.00005 |
| Prostate stem cell antigen | 6.37 | 0.0001 | Moloney leukemia virus 10-like 1 | 3.05 | 0.00005 | |
| Gastric intrinsic factor | 6.07 | 0.00005 | Nuclear receptor subfamily 1, group D, member 1 | 2.55 | 0.00005 | |
| Chemokine (C-X-C motif) ligand 3 | 6.07 | 0.0001 | Unknown | 2.47 | 0.00005 | |
| Serum amyloid A 3 | 5.42 | 0.00005 | Prostaglandin D2 synthase (brain) | 2.46 | 0.00005 | |
| Mucin 5, subtypes A and C, tracheobronchial/gastric | 4.55 | 0.00005 | Myostatin | 2.29 | 0.00005 | |
| Keratin 10 | 4.44 | 0.00005 | Keratin 6B | 2.26 | 0.00005 | |
| Secreted and transmembrane 1B | 4.36 | 0.00005 | Envelope glycoprotein | 2.19 | 0.00005 | |
| Keratin 6B | 3.92 | 0.00005 | Protease, serine 30 | 2.17 | 0.0003 | |
| UDP glucuronosyltransferase 2 family, polypeptide B34 | 3.81 | 0.0006 | Myosin, light polypeptide 2, regulatory, cardiac, slow | 2.17 | 0.00005 | |
| 3 dpi | Immunoresponsive gene 1 | 9.1 | 0.00005 | Chemokine (C-X-C motif) ligand 10 | 8.84 | 0.00005 |
| Chemokine (C-X-C motif) ligand 10 | 7.83 | 0.00205 | Gag-Pol polyprotein | 8.72 | 0.00005 | |
| Gag-Pol polyprotein | 7.58 | 0.00005 | Immunoresponsive gene 1 | 8.08 | 0.00005 | |
| Serum amyloid A 3 | 7.53 | 0.0002 | Chemokine (C-C motif) ligand 7 | 7.6 | 0.00005 | |
| Chemokine (C-X-C motif) ligand 9 | 7.02 | 0.00005 | Serum amyloid A 3 | 7.56 | 0.00005 | |
| Indoleamine 2,3-dioxygenase 1 | 6.96 | 0.00005 | RIKEN cDNA C920009B18 gene | 7.48 | 0.00005 | |
| Lymphocyte antigen 6 complex, locus I | 6.17 | 0.00005 | Chemokine (C-C motif) ligand 2 | 7.12 | 0.00005 | |
| Interferon gamma | 6.14 | 0.00005 | Unknown | 7.06 | 0.0045 | |
| Chemokine (C-C motif) ligand 7 | 6.14 | 0.00005 | Myxovirus (influenza virus) resistance 1 | 6.9 | 0.0045 | |
| Chemokine (C-X-C motif) ligand 2 | 6.13 | 0.00005 | Tripartite motif-containing 30D | 6.79 | 0.00005 | |
| 7 dpi | Ig heavy chain V region MC101 | 10.2 | 0.00805 | Chemokine (C-X-C motif) ligand 11 | 10.4 | 0.021 |
| RIKEN cDNA C920009B18 gene | 8.83 | 0.0009 | Gag-Pol polyprotein | 9.78 | 0.00005 | |
| chemokine (C-X-C motif) ligand 11 | 8.76 | 0.01225 | Immunoresponsive gene 1 | 9.21 | 0.00005 | |
| Gag-Pol polyprotein | 8.03 | 0.00005 | Chemokine (C-C motif) ligand 7 | 9.08 | 0.00005 | |
| Indoleamine 2,3-dioxygenase 1 | 7.43 | 0.00005 | Chemokine (C-X-C motif) ligand 10 | 8.99 | 0.00005 | |
| Chemokine (C-X-C motif) ligand 10 | 7.36 | 0.00005 | Serum amyloid A 3 | 8.72 | 0.00005 | |
| Chemokine (C-C motif) ligand 7 | 7.22 | 0.00005 | RIKEN cDNA C920009B18 gene | 8.64 | 0.00005 | |
| Granzyme B | 6.75 | 0.00005 | Chemokine (C-C motif) ligand 2 | 8.52 | 0.00005 | |
| Immunoresponsive gene 1 | 6.73 | 0.00005 | Chemokine (C-X-C motif) ligand 9 | 8.22 | 0.00005 | |
| Interferon gamma | 6.56 | 0.00005 | Granzyme B | 7.86 | 0.00005 |
Top 10 down-regulated differentially expressed genes (DEGs) in H5N8- and H5N1-infected mice.
| Dpi | H5N8 | Log2 FC | p-value | H5N1 | Log2 FC | p-value |
|---|---|---|---|---|---|---|
| 1 dpi | Myosin, light polypeptide 2, regulatory, cardiac, slow | −8.3 | 0.00005 | Heat shock 70 kDa protein 1A | −3.35 | 0.00005 |
| Immunoglobulin heavy variable 1-73 | −7.25 | 0.00005 | Unknown | −3.21 | 0.00115 | |
| Natriuretic peptide type A | −4.48 | 0.00005 | Phosphoenolpyruvate carboxykinase 1, cytosolic | −2.9 | 0.00005 | |
| Heat shock 70 kDa protein 1A | −3.83 | 0.00005 | Neutrophilic granule protein | −2.71 | 0.00005 | |
| Myosin binding protein C, cardiac | −3.23 | 0.00005 | Chemokine (C-X-C motif) ligand 5 | −2.39 | 0.00075 | |
| Unknown | −3.19 | 0.00005 | Unknown | −2.35 | 0.00005 | |
| Chloride channel calcium activated 3 | −3.05 | 0.00005 | Neuronal PAS domain protein 2 | −2.34 | 0.00005 | |
| LINE-1 reverse transcriptase homolog | −3.01 | 0.0031 | Monoacylglycerol O-acyltransferase 1 | −2.21 | 0.0014 | |
| Corin | −2.9 | 0.00005 | Arachidonate 15-lipoxygenase | −2.16 | 0.00005 | |
| Phosphoenolpyruvate carboxykinase 1, cytosolic | −2.79 | 0.00005 | Ankyrin repeat and EF−hand domain containing 1 | −2.04 | 0.00005 | |
| Immunoglobulin heavy variable 1-73 | −3.97 | 0.00005 | ATPase, H+ transporting, lysosomal V1 subunit B1 | −4.55 | 0.00005 | |
| Unknown | −3.96 | 0.00085 | Unknown | −4.25 | 0.0026 | |
| Thyroid stimulating hormone receptor | −2.74 | 0.00025 | Immunoglobulin heavy variable 1-73 | −4.08 | 0.00005 | |
| Family with sequence similarity 124, member B | −2.5 | 0.00005 | Cytochrome P450 4A12A | −3.51 | 0.00005 | |
| Neuronal PAS domain protein 2 | −2.34 | 0.00005 | Cadherin-like 26 | −3.43 | 0.00005 | |
| 3 dpi | A disintegrin-like and metallopeptidase | −2.3 | 0.00005 | Ig kappa chain V-IV region S107B | −3.42 | 0.0055 |
| Heat shock 70 kDa protein 1A | −2.28 | 0.00005 | Cellular retinoic acid binding protein I | −3.15 | 0.0081 | |
| Solute carrier family 17 (sodium phosphate), member 2 | −2.17 | 0.00075 | CD209a antigen | −3.09 | 0.00005 | |
| phosphoenolpyruvate carboxykinase 1, cytosolic | −2.14 | 0.00005 | Unknown | −3.06 | 0.00005 | |
| Ring finger protein 112 | −2.05 | 0.0018 | Neuronal PAS domain protein 2 | −3.03 | 0.00005 | |
| Myosin, light polypeptide 2, regulatory, cardiac, slow | −9.79 | 0.00005 | Hemoglobin alpha, adult chain 2 | −7.44 | 0.00005 | |
| 7 dpi | Bone morphogenetic protein 10 | −5.08 | 0.00005 | Hemoglobin, beta adult t chain | −7.25 | 0.00005 |
| Unknown | −3.95 | 0.0001 | Hemoglobin alpha, adult chain 1 | −7.01 | 0.00005 | |
| CD209a antigen | −3.67 | 0.00005 | Aminolevulinic, beta adult s chain | −6.75 | 0.00005 | |
| Unknown | −3.55 | 0.00005 | Haemoglobin, beta adult s chain | −6.7 | 0.00005 | |
| Unknown | −3.38 | 0.00005 | Unknown | −6.39 | 0.00005 | |
| Cytochrome P450, family 1, subfamily a, polypeptide 1 | −3.27 | 0.00005 | Fatty acid binding protein 1, liver | −5.6 | 0.00265 | |
| Unknown | −3.23 | 0.00395 | Lactase-like | −5.58 | 0.0198 | |
| Cadherin-like 26 | −3.12 | 0.00005 | Unknown | −5.12 | 0.00005 | |
| Immunoglobulin heavy variable 1-73 | −3.1 | 0.00005 | Solute carrier family 17 (sodium phosphate), number 2 | −5.08 | 0.00005 |
Figure 3Top canonical signalling pathways activated by H5N8 and H5N1 infections.
(A) The Ingenuity pathway analysis (IPA) Tool was used to generate a list of the most significant canonical pathways and the highest activated networks with their respective scores obtained from IPA; 149 (H5N1) and 452 (H5N8). (B) Heatmaps showing the statistical over-representation of the top 20 up or down-regulated DEGs based on the lists of transcripts found as differentially expressed (compared to the mock-infected conditions).
Figure 4Pathway analysis for interferon signalling at 3 days post infection (dpi).
Pathway analysis with IPA software allowed identification of pathways that were differentially expressed between H5N1- and H5N8- infected mice. Genes associated with the interferon signalling canonical pathway that showed differential expression are highlighted in colour. Colour intensity indicates the degree of upregulation (red) or downregulation (green) relative to the mock-infected mice. Solid lines represent direct interactions and dashed lines indirect interactions.
Figure 5Pathway analysis for death receptor signalling at 3 days post infection (dpi).
Pathway analysis with IPA software allowed identification of pathways that were differentially expressed between H5N1- and H5N8- infected mice. Genes associated with the death receptor signalling canonical pathway that showed differential expression are highlighted in colour. Colour intensity indicates the degree of upregulation (red) or downregulation (green) relative to the mock-infected mice. Solid lines represent direct interactions and dashed lines indirect interactions.